drugset
drugset / Trial / NCT05158114

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia

NCT05158114 ↗

Phase 1 Withdrawn The Foundation for Orthopaedics and Regenerative Medicine
NaSingle-groupOpen-labelTreatment

Summary

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Testicular Injury and Oligospermia

Timeline

Start
2025-04-03
Primary completion
2025-04-03
Completion
2025-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AlloRx Cell therapy 1e+08 cells Intravenous

Indications

oligospermia testicular disorder